 | • レポートコード：D005-02975 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：化学・材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、生理活性ペプチドの世界市場を広く調査・分析し、今後の市場展望をまとめております。生理活性ペプチドの種類別市場規模（降圧剤、循環器系、神経系、消化器系、免疫系）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア、通販薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Seagarden、Naturade、Phermpep、Arlak Biotech、WN Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・生理活性ペプチドの北米市場（アメリカ、カナダ、メキシコ） ・生理活性ペプチドのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・生理活性ペプチドのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・生理活性ペプチドの南米市場（ブラジル、アルゼンチン） ・生理活性ペプチドの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：降圧剤、循環器系、神経系、消化器系、免疫系 ・用途別分析：病院薬局、小売薬局、オンライン薬局、ドラッグストア、通販薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Bioactive Peptides market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Bioactive Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Bioactive Peptides market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Bioactive Peptides market has been segmented into
Anti-Hypertensives
Cardiovascular System
Nervous System
Gastrointestinal System
Immune System
By Application, Bioactive Peptides has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Drug Store
Mail-Order Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Bioactive Peptides market presented in the report. This section sheds light on the sales growth of different regional and country-level Bioactive Peptides markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bioactive Peptides market.
The report offers in-depth assessment of the growth and other aspects of the Bioactive Peptides market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Bioactive Peptides Market Share Analysis
Bioactive Peptides competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Bioactive Peptides sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bioactive Peptides sales, revenue and market share for each player covered in this report.
The major players covered in Bioactive Peptides are:
Seagarden
Naturade
Phermpep
Arlak Biotech
WN Pharmaceuticals
Among other players domestic and global, Bioactive Peptides market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bioactive Peptides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bioactive Peptides, with price, sales, revenue and global market share of Bioactive Peptides in 2018 and 2019.
Chapter 3, the Bioactive Peptides competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bioactive Peptides breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Bioactive Peptides market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Bioactive Peptides sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Bioactive Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bioactive Peptides Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Anti-Hypertensives
1.2.3 Cardiovascular System
1.2.4 Nervous System
1.2.5 Gastrointestinal System
1.2.6 Immune System
1.3 Market Analysis by Application
1.3.1 Overview: Global Bioactive Peptides Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Drug Store
1.3.6 Mail-Order Pharmacy
1.4 Overview of Global Bioactive Peptides Market
1.4.1 Global Bioactive Peptides Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Seagarden
2.1.1 Seagarden Details
2.1.2 Seagarden Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Seagarden SWOT Analysis
2.1.4 Seagarden Product and Services
2.1.5 Seagarden Bioactive Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Naturade
2.2.1 Naturade Details
2.2.2 Naturade Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Naturade SWOT Analysis
2.2.4 Naturade Product and Services
2.2.5 Naturade Bioactive Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Phermpep
2.3.1 Phermpep Details
2.3.2 Phermpep Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Phermpep SWOT Analysis
2.3.4 Phermpep Product and Services
2.3.5 Phermpep Bioactive Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arlak Biotech
2.4.1 Arlak Biotech Details
2.4.2 Arlak Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Arlak Biotech SWOT Analysis
2.4.4 Arlak Biotech Product and Services
2.4.5 Arlak Biotech Bioactive Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 WN Pharmaceuticals
2.5.1 WN Pharmaceuticals Details
2.5.2 WN Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 WN Pharmaceuticals SWOT Analysis
2.5.4 WN Pharmaceuticals Product and Services
2.5.5 WN Pharmaceuticals Bioactive Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Bioactive Peptides Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Bioactive Peptides Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Bioactive Peptides Manufacturer Market Share in 2019
3.3.2 Top 6 Bioactive Peptides Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Bioactive Peptides Sales, Revenue and Market Share by Regions
4.1.1 Global Bioactive Peptides Sales and Market Share by Regions (2015-2020)
4.1.2 Global Bioactive Peptides Revenue and Market Share by Regions (2015-2020)
4.2 North America Bioactive Peptides Sales and Growth Rate (2015-2020)
4.3 Europe Bioactive Peptides Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Bioactive Peptides Sales and Growth Rate (2015-2020)
4.5 South America Bioactive Peptides Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Bioactive Peptides Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Bioactive Peptides Sales, Revenue and Market Share by Country
5.1.1 North America Bioactive Peptides Sales and Market Share by Country (2015-2020)
5.1.2 North America Bioactive Peptides Revenue and Market Share by Country (2015-2020)
5.2 United States Bioactive Peptides Sales and Growth Rate (2015-2020)
5.3 Canada Bioactive Peptides Sales and Growth Rate (2015-2020)
5.4 Mexico Bioactive Peptides Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Bioactive Peptides Sales, Revenue and Market Share by Country
6.1.1 Europe Bioactive Peptides Sales and Market Share by Country (2015-2020)
6.1.2 Europe Bioactive Peptides Revenue and Market Share by Country (2015-2020)
6.2 Germany Bioactive Peptides Sales and Growth Rate (2015-2020)
6.3 UK Bioactive Peptides Sales and Growth Rate (2015-2020)
6.4 France Bioactive Peptides Sales and Growth Rate (2015-2020)
6.5 Russia Bioactive Peptides Sales and Growth Rate (2015-2020)
6.6 Italy Bioactive Peptides Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Bioactive Peptides Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Bioactive Peptides Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Bioactive Peptides Revenue and Market Share by Regions (2015-2020)
7.2 China Bioactive Peptides Sales and Growth Rate (2015-2020)
7.3 Japan Bioactive Peptides Sales and Growth Rate (2015-2020)
7.4 Korea Bioactive Peptides Sales and Growth Rate (2015-2020)
7.5 India Bioactive Peptides Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Bioactive Peptides Sales and Growth Rate (2015-2020)
7.7 Australia Bioactive Peptides Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Bioactive Peptides Sales, Revenue and Market Share by Country
8.1.1 South America Bioactive Peptides Sales and Market Share by Country (2015-2020)
8.1.2 South America Bioactive Peptides Revenue and Market Share by Country (2015-2020)
8.2 Brazil Bioactive Peptides Sales and Growth Rate (2015-2020)
8.3 Argentina Bioactive Peptides Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Bioactive Peptides Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Bioactive Peptides Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Bioactive Peptides Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Bioactive Peptides Sales and Growth Rate (2015-2020)
9.3 Turkey Bioactive Peptides Sales and Growth Rate (2015-2020)
9.4 Egypt Bioactive Peptides Sales and Growth Rate (2015-2020)
9.5 South Africa Bioactive Peptides Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Bioactive Peptides Sales and Market Share by Type (2015-2020)
10.2 Global Bioactive Peptides Revenue and Market Share by Type (2015-2020)
10.3 Global Bioactive Peptides Price by Type (2015-2020)
11 Global Bioactive Peptides Market Segment by Application
11.1 Global Bioactive Peptides Sales Market Share by Application (2015-2020)
11.2 Global Bioactive Peptides Revenue Market Share by Application (2015-2020)
11.3 Global Bioactive Peptides Price by Application (2015-2020)
12 Market Forecast
12.1 Global Bioactive Peptides Sales, Revenue and Growth Rate (2021-2025)
12.2 Bioactive Peptides Market Forecast by Regions (2021-2025)
12.2.1 North America Bioactive Peptides Market Forecast (2021-2025)
12.2.2 Europe Bioactive Peptides Market Forecast (2021-2025)
12.2.3 Asia-Pacific Bioactive Peptides Market Forecast (2021-2025)
12.2.4 South America Bioactive Peptides Market Forecast (2021-2025)
12.2.5 Middle East & Africa Bioactive Peptides Market Forecast (2021-2025)
12.3 Bioactive Peptides Market Forecast by Type (2021-2025)
12.3.1 Global Bioactive Peptides Sales Forecast by Type (2021-2025)
12.3.2 Global Bioactive Peptides Market Share Forecast by Type (2021-2025)
12.4 Bioactive Peptides Market Forecast by Application (2021-2025)
12.4.1 Global Bioactive Peptides Sales Forecast by Application (2021-2025)
12.4.2 Global Bioactive Peptides Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Bioactive Peptides Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Bioactive Peptides by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Bioactive Peptides Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Seagarden Basic Information, Manufacturing Base and Competitors
Table 8. Seagarden Bioactive Peptides Major Business
Table 9. Seagarden Bioactive Peptides Total Revenue (USD Million) (2017-2018)
Table 10. Seagarden SWOT Analysis
Table 11. Seagarden Bioactive Peptides Product and Services
Table 12. Seagarden Bioactive Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Naturade Basic Information, Manufacturing Base and Competitors
Table 14. Naturade Bioactive Peptides Major Business
Table 15. Naturade Bioactive Peptides Total Revenue (USD Million) (2017-2018)
Table 16. Naturade SWOT Analysis
Table 17. Naturade Bioactive Peptides Product and Services
Table 18. Naturade Bioactive Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Phermpep Basic Information, Manufacturing Base and Competitors
Table 20. Phermpep Bioactive Peptides Major Business
Table 21. Phermpep Bioactive Peptides Total Revenue (USD Million) (2017-2018)
Table 22. Phermpep SWOT Analysis
Table 23. Phermpep Bioactive Peptides Product and Services
Table 24. Phermpep Bioactive Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Arlak Biotech Basic Information, Manufacturing Base and Competitors
Table 26. Arlak Biotech Bioactive Peptides Major Business
Table 27. Arlak Biotech Bioactive Peptides Total Revenue (USD Million) (2017-2018)
Table 28. Arlak Biotech SWOT Analysis
Table 29. Arlak Biotech Bioactive Peptides Product and Services
Table 30. Arlak Biotech Bioactive Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. WN Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. WN Pharmaceuticals Bioactive Peptides Major Business
Table 33. WN Pharmaceuticals Bioactive Peptides Total Revenue (USD Million) (2017-2018)
Table 34. WN Pharmaceuticals SWOT Analysis
Table 35. WN Pharmaceuticals Bioactive Peptides Product and Services
Table 36. WN Pharmaceuticals Bioactive Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Bioactive Peptides Sales by Manufacturer (2018-2019) (K MT)
Table 38. Global Bioactive Peptides Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Bioactive Peptides Sales by Regions (2015-2020) (K MT)
Table 40. Global Bioactive Peptides Sales Market Share by Regions (2015-2020)
Table 41. Global Bioactive Peptides Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Bioactive Peptides Sales by Countries (2015-2020) (K MT)
Table 43. North America Bioactive Peptides Sales Market Share by Countries (2015-2020)
Table 44. North America Bioactive Peptides Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Bioactive Peptides Revenue Market Share by Countries (2015-2020)
Table 46. Europe Bioactive Peptides Sales by Countries (2015-2020) (K MT)
Table 47. Europe Bioactive Peptides Sales Market Share by Countries (2015-2020)
Table 48. Europe Bioactive Peptides Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Bioactive Peptides Sales by Regions (2015-2020) (K MT)
Table 50. Asia-Pacific Bioactive Peptides Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Bioactive Peptides Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Bioactive Peptides Sales by Countries (2015-2020) (K MT)
Table 53. South America Bioactive Peptides Sales Market Share by Countries (2015-2020)
Table 54. South America Bioactive Peptides Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Bioactive Peptides Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Bioactive Peptides Sales by Countries (2015-2020) (K MT)
Table 57. Middle East & Africa Bioactive Peptides Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Bioactive Peptides Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Bioactive Peptides Revenue Market Share by Countries (2015-2020)
Table 60. Global Bioactive Peptides Sales by Type (2015-2020) (K MT)
Table 61. Global Bioactive Peptides Sales Share by Type (2015-2020)
Table 62. Global Bioactive Peptides Revenue by Type (2015-2020) (USD Million)
Table 63. Global Bioactive Peptides Revenue Share by Type (2015-2020)
Table 64. Global Bioactive Peptides Sales by Application (2015-2020) (K MT)
Table 65. Global Bioactive Peptides Sales Share by Application (2015-2020)
Table 66. Global Bioactive Peptides Sales Forecast by Regions (2021-2025) (K MT)
Table 67. Global Bioactive Peptides Market Share Forecast by Regions (2021-2025)
Table 68. Global Bioactive Peptides Sales Forecast by Type (2021-2025) (K MT)
Table 69. Global Bioactive Peptides Market Share Forecast by Type (2021-2025)
Table 70. Global Bioactive Peptides Sales Forecast by Application (2021-2025)
Table 71. Global Bioactive Peptides Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Bioactive Peptides Picture
Figure 2. Global Sales Market Share of Bioactive Peptides by Type in 2019
Figure 3. Anti-Hypertensives Picture
Figure 4. Cardiovascular System Picture
Figure 5. Nervous System Picture
Figure 6. Gastrointestinal System Picture
Figure 7. Immune System Picture
Figure 8. Bioactive Peptides Sales Market Share by Application in 2018
Figure 9. Hospital Pharmacy Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Online Pharmacy Picture
Figure 12. Drug Store Picture
Figure 13. Mail-Order Pharmacy Picture
Figure 14. Global Bioactive Peptides Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Bioactive Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Bioactive Peptides Sales Market Share by Manufacturer in 2019
Figure 35. Global Bioactive Peptides Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Bioactive Peptides Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Bioactive Peptides Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 40. Global Bioactive Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Bioactive Peptides Revenue Market Share by Regions (2015-2020)
Figure 42. Global Bioactive Peptides Revenue Market Share by Regions in 2018
Figure 43. North America Bioactive Peptides Sales and Growth Rate (2015-2020)
Figure 44. Europe Bioactive Peptides Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Bioactive Peptides Sales and Growth Rate (2015-2020)
Figure 46. South America Bioactive Peptides Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Bioactive Peptides Sales and Growth Rate (2015-2020)
Figure 48. North America Bioactive Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Bioactive Peptides Sales Market Share by Countries (2015-2020)
Figure 50. North America Bioactive Peptides Sales Market Share by Countries in 2018
Figure 51. North America Bioactive Peptides Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Bioactive Peptides Revenue Market Share by Countries in 2018
Figure 53. United States Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Canada Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Mexico Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Europe Bioactive Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Bioactive Peptides Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Bioactive Peptides Revenue Market Share by Countries in 2019
Figure 59. Germany Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 60. UK Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 61. France Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Russia Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Italy Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Asia-Pacific Bioactive Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Bioactive Peptides Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Bioactive Peptides Revenue Market Share by Regions 2019
Figure 67. China Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Japan Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Korea Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 70. India Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Southeast Asia Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 72. South America Bioactive Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Bioactive Peptides Sales Market Share by Countries in 2019
Figure 74. South America Bioactive Peptides Revenue Market Share by Countries in 2019
Figure 75. Brazil Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Argentina Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Middle East and Africa Bioactive Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Bioactive Peptides Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Bioactive Peptides Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Bioactive Peptides Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Egypt Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Turkey Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 84. South Africa Bioactive Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 85. Global Bioactive Peptides Sales and Growth Rate (2021-2025) (K MT)
Figure 86. Global Bioactive Peptides Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Bioactive Peptides Market Forecast (2021-2025) (K MT)
Figure 88. Europe Sales Bioactive Peptides Market Forecast (2021-2025) (K MT)
Figure 89. Asia-Pacific Sales Bioactive Peptides Market Forecast (2021-2025) (K MT)
Figure 90. South America Sales Bioactive Peptides Market Forecast (2021-2025) (K MT)
Figure 91. Middle East & Africa Sales Bioactive Peptides Market Forecast (2021-2025) (K MT)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
生理活性セラミックの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Bioactive Ceramic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bioactive Ceramic market re…- 心血管情報システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cardiovascular Information System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.3% in the forecast period of 2020 to 2025 and will expected to reach USD 928.1 million by 2025, from USD 727.5 million in 2019. The Card…
- 自動車用ピンチ防止パワーウィンドウシステムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Automotive Anti-pinch Power Window System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.3% in the forecast period of 2020 to 2025 and will expected to reach USD 2798.6 million by 2025, from USD 1960.8 million in 2019…
- 対戦車ミサイルシステムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Tank Missile System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Tank Missile Sy…
- 自動車用アンチロックブレーキシステムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Automotive Anti-Lock Braking System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Automotiv…